Scarica l'app Stockscreener
32.00
1.02%
0.314
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$31.69
Aprire:
$31.86
Volume 24 ore:
961.94K
Relative Volume:
0.22
Capitalizzazione di mercato:
$13.95B
Reddito:
$2.27B
Utile/perdita netta:
$1.15B
Rapporto P/E:
12.55
EPS:
2.55
Flusso di cassa netto:
$2.80B
1 W Prestazione:
-1.80%
1M Prestazione:
-5.15%
6M Prestazione:
+17.35%
1 anno Prestazione:
+14.41%
Intervallo 1D:
$31.58
$32.05
Intervallo di 1 settimana:
$31.58
$32.73
Portata 52W:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.00 | 13.95B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.50 | 124.91B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
590.00 | 60.05B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
603.23 | 35.88B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.63 | 29.83B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.68 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement - Insider Monkey
Royalty Pharma plc (NASDAQ:RPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Invesco Ltd. - MarketBeat
Jump Financial LLC Takes $2.09 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bridgewater Associates LP Makes New $1.26 Million Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Synovus Financial Corp - MarketBeat
Cerity Partners LLC Reduces Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Regal Investment Advisors LLC Has $452,000 Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Evergreen Capital Management LLC Has $2.75 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Guggenheim Capital LLC Cuts Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Raymond James Financial Inc. Invests $19.99 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Sterling Capital Management LLC Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Treasurer of the State of North Carolina Sells 10,837 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Keeps Dividend at $0.22 A Share, Payable June 10 to Shareholders of Record May 16 - marketscreener.com
Royalty Pharma plc Announces Second Quarter 2025 Dividend Payment of $0.22 per Class A Ordinary Share - Nasdaq
Royalty Pharma Declares Second Quarter 2025 Dividend - The Manila Times
Royalty Pharma Q2 2025 Dividend: $0.22 Per Share Payable June 10Key Dates and Details - Stock Titan
Bank of Montreal Can Has $3.69 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
BofA Adjusts Price Target on Royalty Pharma to $42 From $41 - marketscreener.com
Portolan Capital Management LLC Purchases 173,721 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Royalty Pharma plc to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Royalty Pharma Schedules Critical Q1 2025 Earnings Release: Key Details for Investors - Stock Titan
Legal & General Group Plc Has $67.19 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management N.V. Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Aviva PLC Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management US Inc. Takes $201,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by CenterBook Partners LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLC - MarketBeat
Russell Investments Group Ltd. Buys 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ADAR1 Capital Management LLC Sells 1,046,703 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Franklin Resources Inc. Sells 921,034 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
JPMorgan Chase & Co. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma modifies acquisition agreement By Investing.com - Investing.com South Africa
Royalty Pharma modifies acquisition agreement - Investing.com
ExodusPoint Capital Management LP Invests $3.66 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Prudential PLC - MarketBeat
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.81%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):